- Home
- ICCT vs MYNZ Comparison
ICCT vs MYNZ Comparison
Compare ICCT & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCT
- MYNZ
- Stock Information
- Founded
- ICCT 1992
- MYNZ 2021
- Country
- ICCT United States
- MYNZ Germany
- Employees
- ICCT N/A
- MYNZ N/A
- Industry
- ICCT Computer Software: Prepackaged Software
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- ICCT Technology
- MYNZ Health Care
- Exchange
- ICCT Nasdaq
- MYNZ Nasdaq
- Market Cap
- ICCT 5.2M
- MYNZ 6.1M
- IPO Year
- ICCT N/A
- MYNZ 2021
- Fundamental
- Price
- ICCT $0.16
- MYNZ $0.24
- Analyst Decision
- ICCT
- MYNZ Buy
- Analyst Count
- ICCT 0
- MYNZ 2
- Target Price
- ICCT N/A
- MYNZ $3.00
- AVG Volume (30 Days)
- ICCT 5.9M
- MYNZ 5.2M
- Earning Date
- ICCT 11-29-2024
- MYNZ 11-26-2024
- Dividend Yield
- ICCT N/A
- MYNZ N/A
- EPS Growth
- ICCT N/A
- MYNZ N/A
- EPS
- ICCT N/A
- MYNZ N/A
- Revenue
- ICCT $10,266,331.00
- MYNZ $917,203.00
- Revenue This Year
- ICCT N/A
- MYNZ $36.69
- Revenue Next Year
- ICCT N/A
- MYNZ $91.67
- P/E Ratio
- ICCT N/A
- MYNZ N/A
- Revenue Growth
- ICCT 34.56
- MYNZ 16.23
- 52 Week Low
- ICCT $0.15
- MYNZ $0.19
- 52 Week High
- ICCT $3.20
- MYNZ $1.79
- Technical
- Relative Strength Index (RSI)
- ICCT 30.94
- MYNZ 45.71
- Support Level
- ICCT $0.17
- MYNZ $0.22
- Resistance Level
- ICCT $0.19
- MYNZ $0.36
- Average True Range (ATR)
- ICCT 0.04
- MYNZ 0.04
- MACD
- ICCT 0.00
- MYNZ 0.00
- Stochastic Oscillator
- ICCT 3.55
- MYNZ 18.59
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.